Zoetis Company Profile (NYSE:ZTS)

About Zoetis (NYSE:ZTS)

Zoetis logoZoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Symbol: NYSE:ZTS
  • CUSIP: 98978V10
  • Web: www.zoetis.com
  • Market Cap: $30.73 billion
  • Outstanding Shares: 490,796,000
Average Prices:
  • 50 Day Moving Avg: $57.03
  • 200 Day Moving Avg: $53.95
  • 52 Week Range: $45.28 - $63.11
  • Trailing P/E Ratio: 36.38
  • Foreward P/E Ratio: 23.45
  • P/E Growth: 2.04
Sales & Book Value:
  • Annual Revenue: $4.96 billion
  • Price / Sales: 6.20
  • Book Value: $3.28 per share
  • Price / Book: 19.09
  • Annual Dividend: $0.42
  • Dividend Yield: 0.7%
  • EBIDTA: $1.71 billion
  • Net Margins: 14.10%
  • Return on Equity: 72.96%
  • Return on Assets: 12.51%
  • Debt-to-Equity Ratio: 2.80%
  • Current Ratio: 3.24%
  • Quick Ratio: 1.73%
  • Average Volume: 3.08 million shs.
  • Beta: 1.07
  • Short Ratio: 1.77

Frequently Asked Questions for Zoetis (NYSE:ZTS)

What is Zoetis' stock symbol?

Zoetis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS."

How often does Zoetis pay dividends? What is the dividend yield for Zoetis?

Zoetis declared a quarterly dividend on Friday, May 12th. Stockholders of record on Thursday, June 15th will be given a dividend of $0.105 per share on Friday, September 1st. This represents a $0.42 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date is Tuesday, June 13th. View Zoetis' Dividend History.

How were Zoetis' earnings last quarter?

Zoetis Inc (NYSE:ZTS) posted its quarterly earnings data on Thursday, May, 4th. The company reported $0.53 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.05. The business had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.20 billion. Zoetis had a net margin of 14.10% and a return on equity of 72.96%. The business's revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.48 EPS. View Zoetis' Earnings History.

When will Zoetis make its next earnings announcement?

Zoetis is scheduled to release their next quarterly earnings announcement on Tuesday, August, 1st 2017. View Earnings Estimates for Zoetis.

What guidance has Zoetis issued on next quarter's earnings?

Zoetis updated its FY17 earnings guidance on Thursday, May, 4th. The company provided EPS guidance of $2.26-2.36 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.32. The company issued revenue guidance of $5.10-5.225 billion, compared to the consensus revenue estimate of $5.17 billion.

Where is Zoetis' stock going? Where will Zoetis' stock price be in 2017?

16 brokerages have issued 1 year price objectives for Zoetis' stock. Their forecasts range from $35.00 to $71.00. On average, they expect Zoetis' share price to reach $59.19 in the next twelve months. View Analyst Ratings for Zoetis.

What are analysts saying about Zoetis stock?

Here are some recent quotes from research analysts about Zoetis stock:

  • 1. According to Zacks Investment Research, "Zoetis’ first-quarter results were better than expected, with the company surpassing bottom-line estimates along with revenues. The growth in revenues was driven by sales of companion animal products such as Simparica, Apoquel and Cytopoint while the livestock portfolio was driven by growth in swine, cattle and fish across the international markets. Zoetis’ expects to see stronger growth from its companion animal portfolio in 2017 driven by Apoquel and Cytopoint, further penetration of Simparica, and ongoing uptake of new vaccines. Favorable market conditions contributed to swine performance in China as well as cattle product sales in Brazil. The company maintained its outlook for 2017. The company received approval for Cytopoint in the European Union in Apr 2017 and in Canada in Mar 2017. Shares of Zoetis have outperformed the industry in the past one year." (5/10/2017)
  • 2. Guggenheim analysts commented, "We are raising our PT for ZTS shares after a 4Q beat and a lower than expected FX headwind for '17. The increase in our PT is driven by multiple expansion. We arrive at our new PT by using a DCF analysis. ZTS's solid execution this quarter increases our confidence that it can exceed consensus expectations for '17+ and sustain its 21x forward P/E multiple. Upward earnings revisions could come from margin expansion, M&A, and launches. Therefore, the sell-off today, which we think is motivated by profit taking, is overdone, in our view. We believe the weakness (ZTS down 3% vs. S&P down 0.14%) presents a good buying opportunity for the stock." (2/16/2017)

Who are some of Zoetis' key competitors?

Who owns Zoetis stock?

Zoetis' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.33%), Vanguard Group Inc. (6.66%), State Street Corp (4.33%), State Farm Mutual Automobile Insurance Co. (3.89%), Morgan Stanley (2.97%) and Independent Franchise Partners LLP (2.28%). Company insiders that own Zoetis stock include Andrew Fenton, Catherine A Knupp, Heidi C Chen, Kristin C Peck, Michael B Mccallister, Pershing Square Capital Manage and Roxanne Lagano. View Institutional Ownership Trends for Zoetis.

Who sold Zoetis stock? Who is selling Zoetis stock?

Zoetis' stock was sold by a variety of institutional investors in the last quarter, including Lazard Asset Management LLC, Principal Financial Group Inc., Marshall Wace LLP, Janus Capital Management LLC, Winslow Capital Management LLC, Alliancebernstein L.P., IronBridge Capital Management LP and Point72 Asset Management L.P.. Company insiders that have sold Zoetis stock in the last year include Andrew Fenton, Catherine A Knupp, Heidi C Chen, Kristin C Peck and Roxanne Lagano. View Insider Buying and Selling for Zoetis.

Who bought Zoetis stock? Who is buying Zoetis stock?

Zoetis' stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Marshall Wace North America L.P., Waddell & Reed Financial Inc., California Public Employees Retirement System, State Street Corp, Prudential Financial Inc. and MARSHALL WACE ASIA Ltd. View Insider Buying and Selling for Zoetis.

How do I buy Zoetis stock?

Shares of Zoetis can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Zoetis stock cost?

One share of Zoetis stock can currently be purchased for approximately $62.61.

Analyst Ratings

Consensus Ratings for Zoetis (NYSE:ZTS) (?)
Ratings Breakdown: 2 Sell Ratings, 3 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $59.19 (5.47% downside)

Analysts' Ratings History for Zoetis (NYSE:ZTS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/26/2017CL KingInitiated CoverageBuy -> Buy$71.00LowView Rating Details
5/24/2017Credit Suisse Group AGBoost Price TargetOutperform$61.00 -> $67.00LowView Rating Details
5/9/2017Jefferies Group LLCBoost Price TargetBuy$65.00 -> $70.00LowView Rating Details
5/4/2017BMO Capital MarketsReiterated RatingBuy$60.00HighView Rating Details
3/15/2017Craig HallumInitiated CoverageBuy$65.00LowView Rating Details
2/16/2017GuggenheimBoost Price TargetBuy$60.00 -> $65.00N/AView Rating Details
2/16/2017Off Wall StreetReiterated RatingStrong Sell$35.00N/AView Rating Details
12/20/2016Deutsche Bank AGInitiated CoverageBuy$62.00N/AView Rating Details
12/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$61.00N/AView Rating Details
12/15/2016Cowen and CompanyUpgradeMarket Perform -> Outperform$50.00 -> $60.00N/AView Rating Details
11/3/2016JPMorgan Chase & Co.Reiterated RatingHold$53.00N/AView Rating Details
10/12/2016Stifel NicolausReiterated RatingBuy$58.00N/AView Rating Details
9/29/2016Bank of America CorpInitiated CoverageBuy$60.00N/AView Rating Details
9/9/2016ArgusBoost Price TargetBelow Average$54.00 -> $58.00N/AView Rating Details
8/4/2016Citigroup IncBoost Price TargetNeutral$50.00 -> $53.00N/AView Rating Details
8/4/2016Barclays PLCBoost Price TargetEqual Weight$45.00 -> $49.00N/AView Rating Details
5/6/2016Goldman Sachs Group IncDowngradeNeutral -> Sell$46.00 -> $48.00N/AView Rating Details
1/8/2016Cleveland ResearchInitiated CoverageBuyN/AView Rating Details
8/6/2015William BlairUpgradeMarket Perform -> OutperformN/AView Rating Details
(Data available from 5/26/2015 forward)


Earnings History for Zoetis (NYSE:ZTS)
Earnings by Quarter for Zoetis (NYSE:ZTS)
Earnings History by Quarter for Zoetis (NYSE:ZTS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2017Q1 2017$0.48$0.53$1.20 billion$1.23 billionViewListenView Earnings Details
2/16/2017Q416$0.45$0.47$1.28 billion$1.30 billionViewN/AView Earnings Details
11/2/2016Q316$0.46$0.52$1.22 billion$1.20 billionViewN/AView Earnings Details
8/3/2016Q216$0.44$0.49$1.17 billion$1.20 billionViewN/AView Earnings Details
5/4/2016Q116$0.41$0.48$1.10 billion$1.20 billionViewN/AView Earnings Details
2/16/2016Q415$0.39$0.43$1.25 billion$1.30 billionViewListenView Earnings Details
11/3/2015Q315$0.40$0.50$1.18 billion$1.20 billionViewN/AView Earnings Details
8/4/2015Q215$0.38$0.43$1.12 billion$1.20 billionViewN/AView Earnings Details
5/5/2015Q115$0.37$0.41$1.11 billion$1.10 billionViewN/AView Earnings Details
2/11/2015Q414$0.36$0.40$1.27 billion$1.30 billionViewN/AView Earnings Details
11/4/2014Q314$0.37$0.41$1.16 billion$1.20 billionViewN/AView Earnings Details
5/6/2014Q114$0.37$0.38$1.13 billion$1.10 billionViewN/AView Earnings Details
2/11/2014Q413$0.34$0.36$1.21 billion$1.25 billionViewN/AView Earnings Details
11/5/2013Q313$0.34$0.34$1.07 billion$1.10 billionViewN/AView Earnings Details
8/6/2013Q2 2013$0.36$0.36$1.13 billion$1.11 billionViewN/AView Earnings Details
4/30/2013Q1 2013$0.27$0.36$1.24 billion$1.09 billionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Zoetis (NYSE:ZTS)
2017 EPS Consensus Estimate: $2.25
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.47$0.49$0.48
Q2 20171$0.50$0.50$0.50
Q3 20171$0.62$0.62$0.62
Q4 20171$0.65$0.65$0.65
(Data provided by Zacks Investment Research)


Current Dividend Information for Zoetis (NYSE:ZTS)
Next Dividend:9/1/2017
Annual Dividend:$0.42
Dividend Yield:0.67%
Dividend Growth:24.90% (3 Year Average)
Payout Ratio:30.44% (Trailing 12 Months of Earnings)
17.95% (Based on This Year's Estimates)
15.73% (Based on Next Year's Estimates)
Track Record:3 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Zoetis (NYSE:ZTS)

Dividend History by Quarter for Zoetis (NYSE:ZTS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Zoetis (NYSE:ZTS)
Insider Ownership Percentage: 0.05%
Institutional Ownership Percentage: 94.54%
Insider Trades by Quarter for Zoetis (NYSE:ZTS)
Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)
Insider Trades by Quarter for Zoetis (NYSE:ZTS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/12/2017Catherine A KnuppInsiderSell5,785$60.16$348,025.60View SEC Filing  
11/22/2016Kristin C PeckInsiderSell10,092$49.55$500,058.60View SEC Filing  
11/8/2016Roxanne LaganoInsiderSell9,797$50.43$494,062.71View SEC Filing  
9/6/2016Michael B MccallisterDirectorBuy2,000$51.34$102,680.00View SEC Filing  
9/2/2016Andrew FentonInsiderSell13,870$51.25$710,837.50View SEC Filing  
9/1/2016Heidi C ChenInsiderSell32,097$50.98$1,636,305.06View SEC Filing  
5/9/2016Pershing Square Capital ManageDirectorSell16,850,000$46.55$784,367,500.00View SEC Filing  
8/8/2013Michael MccallisterDirectorBuy7,000$31.35$219,450.00View SEC Filing  
2/6/2013Frank A DamelioDirectorBuy5,000$26.00$130,000.00View SEC Filing  
2/6/2013Sandra J BeatyEVPBuy2,000$26.00$52,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Zoetis (NYSE:ZTS)
Latest Headlines for Zoetis (NYSE:ZTS)
nasdaq.com logoZoetis Reaches Analyst Target Price
www.nasdaq.com - May 26 at 9:11 AM
finance.yahoo.com logoZoetis to Participate in the Stifel 2017 Dental and Veterinary Conference
finance.yahoo.com - May 26 at 9:11 AM
americanbankingnews.com logoZoetis Inc (ZTS) Research Coverage Started at CL King
www.americanbankingnews.com - May 26 at 9:04 AM
finance.yahoo.com logoHorizon (HZNP) Sells European Rights for Procysbi & Quinsair
finance.yahoo.com - May 25 at 8:13 AM
americanbankingnews.com logoCredit Suisse Group AG Reiterates Outperform Rating for Zoetis Inc (ZTS)
www.americanbankingnews.com - May 24 at 9:34 PM
streetinsider.com logoZoetis (ZTS): Raising PT - Credit Suisse - StreetInsider.com
www.streetinsider.com - May 24 at 8:00 AM
finance.yahoo.com logoCelgene (CELG) Multiple Sclerosis Drug Meets Primary Endpoint
finance.yahoo.com - May 23 at 8:14 PM
fool.com logoCan These 3 High-Flying Healthcare Stocks Reach the Clouds?
www.fool.com - May 23 at 3:22 PM
fool.com logo3 Top Animal-Health Companies to Buy in 2017
www.fool.com - May 21 at 3:20 PM
finance.yahoo.com logoWhat’s Really Driving Zoetis’s Margins in 2017?
finance.yahoo.com - May 19 at 1:57 PM
finance.yahoo.com logoInside Zoetis’s Growth Strategy in 2017
finance.yahoo.com - May 19 at 1:57 PM
finance.yahoo.com logoBehind Zoetis’s Multi-Pronged Strategy to Strengthen Its Product Portfolio
finance.yahoo.com - May 18 at 8:15 AM
finance.yahoo.com logoInside Zoetis’s Key Revenue Drivers
finance.yahoo.com - May 17 at 11:42 PM
finance.yahoo.com logoWhy Zoetis’s Apoquel and Cytopoint Are Expected to Report Robust Revenues
finance.yahoo.com - May 17 at 11:42 PM
finance.yahoo.com logoWhy Zoetis Expects to See Robust Revenue Growth in 2017
finance.yahoo.com - May 17 at 8:04 AM
finance.yahoo.com logoZoetis CEO sees more future growth in treating pain for cats, dogs
finance.yahoo.com - May 17 at 12:20 AM
finance.yahoo.com logoZoetis: Cramer's Top Takeaways
finance.yahoo.com - May 16 at 8:00 AM
finance.yahoo.com logoZoetis CEO says new drug is a game-changer for treating pain in cats, dogs
finance.yahoo.com - May 15 at 7:55 PM
finance.yahoo.com logoZoetis CEO says new drug is a game-changer for treating p...
finance.yahoo.com - May 15 at 7:55 PM
finance.yahoo.com logoCramer Remix: Why China may have just beaten Washington
finance.yahoo.com - May 15 at 7:55 PM
americanbankingnews.com logoZoetis Inc (ZTS) Insider Sells $348,025.60 in Stock
www.americanbankingnews.com - May 15 at 7:30 PM
americanbankingnews.com logoZoetis Inc (ZTS) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 15 at 2:46 PM
americanbankingnews.com logoZoetis Inc (ZTS) Announces $0.11 Quarterly Dividend
www.americanbankingnews.com - May 12 at 5:50 PM
finance.yahoo.com logoZoetis Declares Third Quarter 2017 Dividend
finance.yahoo.com - May 11 at 8:28 PM
finance.yahoo.com logoZoetis Holds Annual Meeting of Shareholders
finance.yahoo.com - May 11 at 3:26 PM
americanbankingnews.com logoZoetis Inc (ZTS) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - May 10 at 11:40 AM
americanbankingnews.com logoFY2017 EPS Estimates for Zoetis Inc Increased by Jefferies Group (ZTS)
www.americanbankingnews.com - May 10 at 9:38 AM
streetinsider.com logoZoetis (ZTS): Crushing The Bears - Jefferies - StreetInsider.com
www.streetinsider.com - May 10 at 8:46 AM
americanbankingnews.com logoJefferies Group LLC Reaffirms "Buy" Rating for Zoetis Inc (ZTS)
www.americanbankingnews.com - May 9 at 9:14 PM
finance.yahoo.com logoForbes Names Zoetis One of America’s Best Employers for Second Year in a Row
finance.yahoo.com - May 9 at 9:00 PM
finance.yahoo.com logoEdited Transcript of ZTS earnings conference call or presentation 4-May-17 12:30pm GMT
finance.yahoo.com - May 8 at 9:13 PM
finance.yahoo.com logoZoetis Strengthens Its Commitment to Develop Sustainable Livestock Production in Sub-Saharan Africa
finance.yahoo.com - May 8 at 9:13 PM
americanbankingnews.com logoEquities Analysts Set Expectations for Zoetis Inc's Q2 2017 Earnings (ZTS)
www.americanbankingnews.com - May 8 at 8:21 AM
streetinsider.com logoZoetis Inc. (ZTS) PT Raised to $64 at BMO Capital - StreetInsider.com
www.streetinsider.com - May 6 at 3:45 PM
bloomberg.com logoRecent ZTS News
www.bloomberg.com - May 5 at 5:54 AM
streetinsider.com logoZoetis Inc. (ZTS) PT Raised to $64 at BMO Capital
www.streetinsider.com - May 5 at 5:54 AM
seekingalpha.com logoZoetis (ZTS) Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 5 at 5:54 AM
finance.yahoo.com logoZoetis (ZTS) Beats Earnings, Revenue Estimates in Q1
finance.yahoo.com - May 5 at 5:54 AM
americanbankingnews.com logoZoetis Inc (ZTS) Receives "Buy" Rating from BMO Capital Markets
www.americanbankingnews.com - May 4 at 11:56 PM
americanbankingnews.com logoZoetis Inc (ZTS) Announces Earnings Results, Beats Expectations By $0.05 EPS
www.americanbankingnews.com - May 4 at 4:00 PM
seekingalpha.com logoZoetis Q1 revenues up 6%; non-GAAP EPS up 10%; reiterates guidance
seekingalpha.com - May 4 at 11:12 AM
americanbankingnews.com logoZoetis Inc to Post Q1 2017 Earnings of $0.47 Per Share, Jefferies Group Forecasts (ZTS)
www.americanbankingnews.com - May 4 at 10:44 AM
americanbankingnews.com logoZoetis Inc (ZTS) Releases FY17 Earnings Guidance
www.americanbankingnews.com - May 4 at 10:36 AM
zacks.com logoZoetis (ZTS) Tops Earnings & Sales in Q1, Keeps 2017 View
www.zacks.com - May 4 at 9:23 AM
finance.yahoo.com logoZoetis Announces First Quarter 2017 Results
finance.yahoo.com - May 4 at 9:23 AM
marketbeat.com logoZoetis beats Street 1Q forecasts
marketbeat.com - May 4 at 7:31 AM
finance.yahoo.com logoDrug Stock Q1 Earnings Releases on May 4: ZTS, REGN & More
finance.yahoo.com - May 3 at 9:31 AM
finance.yahoo.com logoZoetis to Participate in the Bank of America Merrill Lynch Health Care Conference
finance.yahoo.com - May 2 at 6:55 PM
americanbankingnews.com logoZoetis Inc (ZTS) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - May 2 at 1:27 PM
americanbankingnews.com logoZoetis (ZTS) Receiving Somewhat Favorable Media Coverage, Report Finds
www.americanbankingnews.com - May 2 at 10:36 AM



Zoetis (ZTS) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff